About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 603 record(s)
Req # A-2020-000497
In Health Canada’s report to the Framework Convention on Tobacco Control, reference is made to "AC Nielsen tobacco retail sales reports prepared for Health Canada (2019)". A copy of this report.Organization: Health Canada
January 2024
Req # A-2020-000962
All sales data which Health Canada possesses, from any sources, for vaping products for Q3/4 2019 and for Q1/2 2020.Organization: Health Canada
January 2024
Req # A-2020-001438
Provide documents for all renovations, office improvements, redecorating, furniture purchases, made for the Chief Public Health Officer’s office, since November 1, 2019.Organization: Health Canada
January 2024
Req # A-2020-001817
All Briefing Notes, Issue sheets, Memorandums, Treasury Board Submissions, Standard Operating Processes, security assessment and incident templates, Internal Audits, PowerPoint presentations, and similar reports evaluating Health Canada’s readiness to handle cyber attacks and/or data breaches.Timeframe: January 1, 2018 to March 5, 2021.Organization: Health Canada
January 2024
Req # A-2021-000555
The document titled Expert Elicitation on the Behavioural impacts of Nicotine Standards which could explain how the five experts who were chosen and what process or data led to the experts decision that vaping was 20% as dangerous as smoking.Organization: Health Canada
January 2024
Req # A-2021-001762
All submissions received by the department further to its consultation on the subject of per- and polyfluoralkyl substances (PFAS) launched on April 24th, 2021.Organization: Health Canada
January 2024
Req # A-2021-001859
Any records on the human rights of intersex people, people with Differences in Sex Development (DSD), or people who underwent the surgeries. Any records on medical care to treat intersex people, DSD, or people who underwent the surgeries. Any records on the funding of medical care to treat intersex. people, DSD, or people who underwent the surgeries. Any records on the medical outcomes and prognosis of intersex people, DSD, or people who underwent the surgeries. Any records of consultations undertaken with intersex people, Intersex groups, people with DSD, or people who underwent the surgeries. Any records of the number of surgeries performed in Canada, individually and collectively. From 1993 to 2022-01-28.Organization: Health Canada
January 2024
Req # A-2021-001998
Documents regarding the approval process for Pfizer-BionTech BNT162b2 vaccine.Organization: Health Canada
January 2024
Req # A-2022-000412
For the period beginning January 1, 2021 to June 28, 2022, all records and documentation related to any complaints received and/or investigations conducted by Health Canada; and correspondence between Health Canada and Canadian Food Inspection Agency (CFIA) in respect of the compliance of BioSteel brand products with regulatory obligations, including those pertaining to product labelling, advertising and formulations.Organization: Health Canada
January 2024
Req # A-2022-000449
Correpondence relating to any abbreviated new drug submission filed since March 1, 2022 where the dosage form is a desmopressin orally disintegrating tablet (melt tablet). Exclude module 3 and 5.Organization: Health Canada
January 2024